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Abstract
Background: Mentalizing, the mental capacity to understand oneself and others in terms of mental states, has
been found to be reduced in some mental disorders such as Borderline Personality Disorder (BPD). Some studies
have suggested that Eating Disorders (EDs) may also be associated with impairments in mentalizing, but studies
have not always yielded consistent results. This is the first study to systematically investigate mentalizing
impairments in patients with Bulimia Nervosa (BN) compared with controls. In addition, we investigated whether
impairments in mentalizing were related to BPD features, rather than BN per se, given the high comorbidity
between BPD and BN.
Methods: Patients with BN (n = 53) and healthy controls (HCs; n = 87) completed a battery of measures assessing
mentalizing including the Reflective Function Questionnaires (RFQ), the Object Relations Inventory (ORI;
Differentiation-Relatedness Scales) and the Reading The Mind in The Eyes Test (RMET).
Results: Patients with BN scored significantly lower than HCs on all tests of mentalizing, with moderate to
large between-group effect sizes. These differences were partially accounted for by BPD features as assessed
with the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD), and partially by bulimic
symptoms measured with the Eating Disorder Examination Questionnaire (EDE-Q).
Conclusions: Patients with BN have significantly lower levels of mentalizing as assessed with a broad range
of tests compared to HCs. These differences were related to both bulimic symptoms and BPD features.
Although further research in larger samples is needed, if replicated, these findings suggest that poor
mentalizing may be a significant factor in BN patients and should be addressed in treatment, regardless of
the presence of BPD features.
Keywords: Bulimia nervosa, Borderline personality disorder, Eating disorder, Mentalizing, Theory of mind,
Differentiation-relatedness, Reading the mind in the eyes, Reflective function
Background
Bulimia Nervosa (BN) is a debilitating and complex
Eating Disorder (ED) characterized by the presence of
binging and purging episodes which are generally
accompanied by excessive concern about body weight
and shape as well as body image disturbance [1, 28].
The onset of BN usually occurs during adolescence or
early adulthood. Nonetheless, the disorder tends to per-
sist for several years after onset, with a chronic or inter-
mittent course [1, 8]. In general, EDs are a family of
psychopathologies often resistant to treatment with high
relapse rates [28, 37]. Relapse remains a significant con-
cern in BN with rates that range between 27.6 and 41%
within 2 years after remission [47, 49]. Moreover, the
vast majority of relapses occur in the first months after
treatment completion [49]. In light of this data, it is im-
portant to clarify the core psychological mechanisms
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that sustain the disorder and that should be addressed
during treatment [28].
In this respect, it has been postulated that EDs might
develop as a result of emotional difficulties [8]. In-
deed, the importance of addressing mood intolerance
and emotion dysregulation has been stressed in
different treatment protocols including enhanced
cognitive behavioural therapy (CBT-E; [27]) and in
dialectical behavioural therapy (DBT; [64]).
Moreover, several studies have linked ED symptoms
with deficits in mentalizing suggesting that emotional
difficulties in this population may arise from a lack of
imaginative mental activity about intentional mental
states [23, 40, 48, 50]. The term mentalizing indeed re-
fers to the capacity to be aware of both self-experience
and interpersonal experience of mental states [4, 7]. In
other words, mentalizing implies perceiving and inter-
preting human behaviours as the result of subjective
states and mental processes, such as needs, desires, feel-
ings, thoughts and beliefs. Mentalizing provides the indi-
vidual with the capacity to understand the
representational nature of mind and to distinguish be-
tween internal and external reality [34]. This capacity, in
turn, is deemed to be essential for recognizing and regu-
lating emotions effectively [5].
BN patients have been shown to demonstrate problems
with regard to mentalizing about the self, as expressed in
high levels of alexithymia (the inability to label emotions),
accompanied by an impaired capacity for symbolization
(the capacity to create symbolic representations; [22, 36,
57, 58]). Consistent with these findings, bulimic symptoms
have been conceptualized as maladaptive strategies for
managing affects in the presence of impaired emotion rec-
ognition and regulation [20, 50].
Furthermore, not only do individuals with EDs have
difficulty recognizing their own emotional states, but
they also show impairments in acknowledging other
people’s emotions [17, 39]. In this respect, a recent
meta-analysis reported emotion recognition in others to
be impaired both in Anorexia Nervosa (AN) and BN pa-
tients. However, more severe deficits were found in
acute AN, while BN was associated with only a small im-
pairment [17]. In light of these personal and interper-
sonal deficits in emotion recognition, it has been
proposed that reduced ability to mentalize could be a
key feature of ED psychopathology [34].
Yet, studies focused on mentalizing in BN are still
scarce, and some research has failed to find mentaliz-
ing impairments in BN [50, 51]. In fact, some studies
have shown bulimic patients to have average or even
superior mentalizing abilities compared to healthy
subjects [19, 43, 50, 55]. Accordingly, Pedersen et al.
[50] reported a bimodal distribution in BN, suggesting
two distinct subgroups within BN with regard to
mentalizing (high vs. low abilities). Therefore, re-
search on this topic might benefit from identifying
additional factors that could account for this variabil-
ity in mentalizing that has been observed in BN
groups. In this respect, recent analyses have shown
that up to 20% of ED patients also meet criteria for
BPD [52]. Moreover, a larger proportion of patients,
although not fulfilling BPD criteria, are deemed to
present with BPD features [59]. However, no previous
studies assessing mentalizing in BN have controlled
for comorbid BPD symptoms. Given that BPD has
been long associated with impaired mentalizing, it
might be the case that this variable might contribute
to some of the heterogeneity observed in previous
results [3–5].
In this respect, recent lines of research challenged the
use of the categorical diagnostic approach in relation to
EDs. Instead, Q-sort analyses on large samples of pa-
tients discriminated separate trans-diagnostic ED pro-
files with distinct comorbidities and personality traits
[60, 63]. According to this research, a consistent propor-
tion of ED patients are characterized by high levels of
impulsivity and BPD personality traits. However, other
ED patients can show very different profiles with
obsessive-compulsive and perfectionistic features or
avoidant and depressive tendencies [60, 65].
Considering this heterogeneity of profiles and the
above-mentioned relationship between BPD and im-
paired mentalizing, we hypothesize that BN subjects
with lower levels of comorbid BPD symptoms will show
better mentalizing, while those with higher levels of BPD
comorbidity will have poorer mentalizing. This approach
is consistent with both the categorical approach to EDs,
separating patients into groups with different
co-morbidities, and the phenomenological approach, in
which a variety of symptoms, viewed as dimensions, re-
flect a common underlying pathology. In the present
study, mentalizing, ED symptoms, BPD symptoms and
general psychopathology were assessed in a sample of
BN patients and healthy controls (HCs). We focused on
several dimensions of mentalizing: uncertainty (hypo-
mentalizing) and certainty (in the extreme hypermer-
mentalizing) in interpreting mental states (Reflective
Function Questionnaire); externally-based mentalizing
such as others’ emotion recognition (Reading the Mind
in the Eyes Test); and the level of differentiation and re-
latedness in descriptions of self and others (Differentia-
tion-Relatedness Scale).
The following study hypotheses were tested:
1) BN patients would show lower scores in
mentalizing measures compared to HCs. However,
we expected differences between groups to
decrease, when controlling for BPD features.
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2) Lower scores in mentalizing in the BN sample were
expected to be associated with higher ED symptoms
severity. However, we also expected this
relationship to level down when controlling for
BPD features.
3) Finally, we tested a mediation model with BPD
features as a mediator between Group (BN vs. HC)
and mentalizing level.
Methods
Participants and procedures
The study protocol was reviewed and approved by
the South East Research Ethics Committee (REC)
and the London - Fulham NHS REC. In total 140
participants were included in the study with n = 53
BN patients and n = 87 HCs. Recruitment took place
between July 2011 and May 2017. Part of the study
population was assessed between 2011 and 2012 dur-
ing a Randomized Clinical Trial (RCT) for evaluating
the efficacy of a newly developed mentalization-
based treatment (MBT) for EDs [53]. This subsample
consisted of 43 BN patients and 62 HC. Data regard-
ing BN patients were collected at baseline, before
the beginning of the treatment. During the first half
of 2017, an additional sample of 10 patients and 25
HC was recruited to increase the sample size based
on a priori power analysis using G*Power 3.0.10
[30], which indicated that a total sample of n = 84
was needed to detect a large effect (Cohen’s d = .8)
with 95% power, using a t test for independent
samples with alpha at .05 (two tailed). The total
number of participants in the present study was
therefore n = 53 BN, n = 87 HC, n = 140 Total.
The clinical sample was recruited from three NHS trusts
and consisted of outpatients between 18 and 55 years of age
with a diagnosis of BN. Eating Disorder diagnoses were
confirmed by means of the Eating Disorder
Examination-Questionnaire (EDE-Q: [21]) according to
DSM-5 diagnostic categories [1]. Borderline personality dis-
order was diagnosed using the SCID interview [32]. As
questionnaires and interviews were conducted in English,
fluency with the language was required as inclusion criteria.
Additional exclusion criteria were a history or current diag-
nosis of Schizophrenia Spectrum And Other Psychotic Dis-
orders, Autistic Spectrum Disorders (ASDs), severe brain
damage and organic brain diseases leading to significant
cognitive impairment. For the 43 subjects who were
assessed during the first wave of testing (2011–2012), fur-
ther inclusion criteria were the presence of suicidal or
self-injurious behaviors and impulsivity in at least two areas
(e.g. sexual behaviors, spending, substance abuse). As we
intended to have a sample of BN with different degrees of
BPD symptomatology, these criteria were not maintained
for the second wave of testing (2017).
The HCs were recruited from University College
London and from the community. Recruitment was
carried out through the UCL Psychology Subject Pool
as well as flyers and advertisements. Participants were
asked to take part in the study if they had “no history
of or current Eating Disorders or any mental health
difficulty requiring treatment”. Moreover, participants
with a BMI lower than 18.5 kg/m2 or not fluent in
English were excluded from the sample. In addition,
the last 25 HCs, corresponding to the second wave of
testing, were administered the EDE-Q and the
ZAN-BPD, and had their BMI measured to confirm
the absence of ED and BPD diagnoses. Therefore,
data regarding the BMI, EDE-Q and ZAN-BPD are
available for only a portion of HCs representing 29%
of the HC sample. However, measures were included
in the analyses as post-hoc power calculations, based
on the effect sizes found, revealed that results of the
comparisons between groups were sufficiently pow-
ered (BMI: β < .02; EDE-Q: β < .001; ZAN-BPD: β
< .001). All HCs were paid with a £10 Amazon vou-
cher for their participation.
The BN sample was mostly (94.3%) female (F, n = 50;
M, n = 3). The HCs contained 87.4% female participants
(F, n = 76; M, n = 11). The distribution of gender between
the two groups did not significantly differ, χ2 (1, N =
140) = 1.78, p = .24.
Before the beginning of the study, all participants re-
ceived an information sheet explaining the goals and the
procedure of the research. Eligible participants were
then asked to provide written informed consent. Subse-
quently, a trained masters student administered to them
the Demographics Questionnaire, EDE-Q, RFQ, RMET,
Depression Anxiety Stress Scales (DASS-21), ZAN-BPD
and ORI. The three descriptions of the ORI were re-
corded and transcribed. Afterwards, two independent as-
sessors analysed the transcripts according to the DR-S.
When scores were different, cases were discussed until
agreement was reached. The inter-rater reliability be-
tween the two assessors was high with an average ICC
of .93. Finally participants were debriefed and thanked.
However, not all the participants in the HC group
completed the whole battery of tests assessing mentaliz-
ing. As testing was found distressing and a burden by
some participants, during the first wave of testing the
authors decided to drop some of the scales. The mini-
mum number of HCs per each main outcome measures
was 51. The number of participants who completed each
measure is reported in the result section (Table 1).
Measures/instruments
Demographics questionnaire
Demographic information of participants was assessed
by means of a preliminary questionnaire including
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gender, age, level of education, height, weight and psy-
chiatric history.
Eating disorders examination-questionnaire (EDE-Q; [25, 26])
ED diagnosis and symptom severity were assessed
using the EDE-Q which consists of a self-report 28
item questionnaire adapted from the Eating Disorders
Examination interview (EDE; [29]). Participants were
required to indicate the frequency to which they ex-
perienced ED symptoms over the previous four weeks.
For the purposes of the current study, we focused on
the EDE-Q Global score to assess the overall attitude
towards food, body and weight of participants. The
EDE-Q has been proven to have a good internal
consistency (α = between .70 and 0.93; [9]). In this
sample, for the Global EDE-Q score, we obtained a
high level of internal consistency, α = .95.
Reflective function questionnaire (RFQ; [35])
The RFQ is a self-report questionnaire to assess cap-
acity for mentalization in the context of attachment.
It consists of 54 items that are rated on a 6-point
Likert scale (from 1 = “strongly disagree” to 6
= “strongly agree”). Sample items include the follow-
ing: “People’s thoughts are a mystery to me”, “I al-
ways know what I feel” and “I don’t always know why
I do what I do”. Exploratory and confirmatory factor
analyses in clinical and nonclinical samples yielded six
items with high loading on two factors, namely “cer-
tainty about mental states” (RFQ-C) and “uncertainty
about mental states” (RFQ-U; [34]). Thus, these two
scales were used in the current study. Higher scores
on the RFQ-C reflect the acknowledgement of mental
states’ opaqueness and therefore a more genuine level
of mentalizing. Conversely, lower scores are deemed
to reflect hypermentalizing (the tendency to
over-interpret mental states), which has been docu-
mented in patients with EDs [34]. On the other hand,
the RFQ-U is used to assess of hypomentalizing (lack
of knowledge about mental states). Specifically, higher
scores on the RFQ-U are thought to reflect the ten-
dency to think in concrete, non-mentalizing terms,
while lower scores indicate better mentalizing [34]. In
the current sample, the RFQ-U and the RFQ-C
showed respectively a good (α = .76) and an excellent
(α = .80) internal consistency.
Table 1 Means and standard deviations of the study variables, and between-group effect sizes
Condition N Mean (SD) 95% Confidence Interval
Lower Bound Upper Bound Effect size
Age BN 53 30.60 (8.91) 28.14 33.05 NS
HC 87 29.14 (8.65) 27.30 30.98
BMI BN 53 23.55 (6.09) 21.87 25.23 NS
HC 25 21.63 (2.72) 20.50 22.75
EDE-Q BN 53 4.47 (0.82) 4.24 4.70 4.01
HC 25 0.94 (0.75) 0.63 1.25
DASS-21 BN 53 38.26 (11.16) 35.18 41.34 3.89
HC 50 9.62 (8.68) 7.15 12.09
DR-S Self BN 53 5.38 (1.04) 5.10 5.67 1.08
HC 87 6.44 (0.92) 6.24 6.63
DR-S Mother BN 53 5.55 (1.08) 5.25 5.84 0.42
HC 87 6.19 (0.82) 6.02 6.37
DR-S Father BN 53 5.90 (0.91) 5.65 6.15 0.45
HC 87 6.31 (0.91) 6.12 6.50
RMET BN 53 26.09 (3.88) 25.02 27.16 0.62
HC 51 28.27 (3.19) 27.38 29.17
RFQ-C BN 53 2.56 (2.53) 1.86 3.26 1.46
HC 51 7.90 (4.76) 6.56 9.24
RFQ-U BN 53 8.90 (4.47) 7.67 10.13 1.90
HC 51 1.90 (2.88) 1.09 2.71
ZAN-BPD BN 53 15.85 (5.45) 14.35 17.35 2.90
HC 25 4.08 (2.67) 2.97 5.18
Note. BN Bulimia Nervosa patients, HC Healthy controls. For EDE-Q, DASS-21, and ZAN-BPD total scores are reported
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Reading the mind in the eyes test-revised (RMET-R; [2])
This task includes 36 pictures of the eye region illustrat-
ing different emotionally charged or neutral mental
states. Each picture is paired with four words represent-
ing different complex mental states (e.g., irritated, bored,
ashamed). On a given trial, participants are asked to
match each picture with the one word that better de-
scribes that mental state illustrated. The RMET-R is a
performance-based measure of the level of Theory of
Mind (ToM). Higher scores reflect higher ability to
understand other people’s mental states, while lower
scores indicate a deficit in this area. Previous research
provided evidence for adequate test–retest reliability
(ICC = .83) as well as internal reliability of this measure
(α = .60; [38, 61]).
Differentiation-relatedness scale (DR-S; [24])
The DR-S is a procedure for assessing the level of inte-
gration, differentiation, and relatedness of self and
significant others. The assessment is based on the Object
Relations Inventory (ORI; [12]), a semi-structured inter-
view for the assessment of object representations. The
ORI consists in three open-ended descriptions of the
mother, the father and the self. According to the DR-S,
each description is then rated by an independent exam-
iner on a 10-point scoring system, ranging from 1 to 10.
Lower scores indicate primitive levels of object represen-
tations with compromised boundaries between the self
and the others and an immature sense of interpersonal
relatedness. Relationships are described primary in terms
of the gratification or frustration, and there is little
sense of the existence of others as separate entities
independent to the subject [13]. Conversely upper
scale levels reflect more complex and healthy object
relations. Descriptions are more nuanced and coher-
ent, reflecting an increasing capacity to integrate dis-
parate aspects of self and other with increasing
tolerance for ambivalence and ambiguity [13]. The in-
strument has been proven to be a valid and reliable
measure of object representations [15, 18, 44]. The
inter-rater reliabilities ranged from r = .80 to r = .99
[14, 16]. In the current sample, the internal reliability
between the two assessors was proven to be high with
an average ICC of .93.
Zanarini rating scale for borderline personality disorder
(ZAN-BPD; [66])
The ZAN-BPD is a clinician-administered semi-struc-
tured interview for the assessment of BPD symptom se-
verity. Each symptom domain is rated on a 5-point
Likert Scale from 0 (no symptoms) to 4 (severe symp-
toms). The total score of ZAN-BPD provides a continu-
ous measure of BPD psychopathology from a minimum
of 0 to a maximum of 36. The scale has excellent
internal reliability in non-clinical (α = 0.89) and clinical
samples (α = 0.94; [34]).
Depression anxiety stress scales (DASS-21; [46])
The DASS-21 is a self-report questionnaire including 21
items tapping into three subscales: anxiety, depression
and stress. For this study, we focused on the total score
of the scale as a general measure of psychological dis-
tress. The DASS-21 has been shown to have high in-
ternal consistency (α = .93; [42]).
Statistical analysis
Analysis of variance (ANOVA) was used to examine
group differences with Group (BN vs. HC) as the inde-
pendent variable and age, BMI, EDE-Q, DASS-21, ORI
Self, ORI Mother, ORI Father, RMET, RFQ-C, RFQ-U
and ZAN-BPD as dependent variables. Before analyzing
between group differences, we performed Kolmogorov-
Smirnov (K-S) and Levene’s tests to check for normality
and variance homogeneity assumptions. Although some
variables did not meet these assumptions, we used para-
metric tests as the overall F test is fairly robust against
the violation of assumptions concerning normality [31].
Cohen’s d effect sizes were calculated as an additional
index of between-group differences.
To take account of potential confounders for between
groups differences in mentalizing, we intended to per-
form an analysis of covariance (ANCOVA) entering the
total scores of the ZAN-BPD as a covariate. However, as
the assumption of homogeneity of regression slopes was
not met, ANCOVA could not be performed. ZAN-BPD
scores showed a bimodal distribution with low scores
characterizing HCs and high scores the BN sample. In-
deed, the interaction term between ZAN-BPD and
Group was found to be significant, F(1,101) = 2.38, p
< .05. In order to further analyze the direction of this
interaction, we performed two separate regressions for
HCs and BN entering ZAN-BPD as the independent
variable, and measures of mentalizing as dependent vari-
ables. Furthermore, we performed a t-test comparing
mentalizing abilities in BN subjects with high and low
BPD symptoms. To this aim, as suggested by previous
literature, a score of 9 on the ZAN-BPD was used as
cutoff [45]. Only 7 patients within the BN sample had a
ZAN-BPD score < 9, while the vast majority (n = 53) had
scores above the cut-off.
Pearson correlations were calculated to assess the
relationship between the different variables within the
BN sample. No subsequent regression analyses were
performed as variables did not meet the assumptions of
normality and multicollinearity.
Lastly, we tested mediation models entering Group as
independent variable, measures of mentalizing as
dependent variable, and ZAN-BPD scores as mediator.
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Mediation models were only tested for mentalizing mea-
sures that showed a significant correlation with ED
(EDE-Q), BPD symptoms (ZAN-BPD) or with psycho-
logical distress (DASS-21) in the BN sample. As a result,
three mediation models were tested, using the RFQ-C,
RFQ-U and DR-S Self as dependent variables,
respectively.
Statistical analyses were performed using SPSS soft-
ware package Version 23. Mediation models were tested
with the PROCESS macro for SPSS [41]. Missing values
with a rate ≤ 20% per sample were estimated using the
Expectation-Maximization method [62]. All statistical
analyses were conducted two-tailed with an alpha level
of .05.
Results
Table 1 presents the means and standard deviations of
all variables in the BN and the HC sample. The results
of the ANOVA comparing the means in the two samples
on the study variables are shown in Table 2. BN patients
and HCs did not significantly differ in their age distribu-
tion and there was no statistical difference in BMI be-
tween both samples.
Moreover, before testing the study hypotheses, we ex-
amined the extent to which BN patients and HCs dif-
fered in terms of ED symptoms (EDE-Q) and general
psychological distress (DASS-21). As expected, BN pa-
tients were significantly higher in all subscales of the
EDE-Q, with scores above the clinical threshold for each
subscale. Conversely, controls showed a distribution of
ED symptoms within the community norms [25]. As
shown in Table 2, BN reported significantly elevated
scores on the EDE-Q and DASS-21 compared to HCs.
In addition, BN patients scored significantly higher on
the total score of the ZAN-BPD. Moreover, as expected,
BN patients had significantly lower scores on all mea-
sures of mentalizing compared to HCs (Fig. 1). Effect
sizes were moderate to large.
Regarding the first hypothesis, we found that all mea-
sures of mentalizing in BN showed significantly lower
scores compared to controls with moderate to large ef-
fect sizes (Table 1). In the second part of the first hy-
pothesis we suggested that variation in the ZAN-BPD
would account for at least some of the group effect. The
Group x ZAN-BPD interaction was significant, and
therefore it was not possible to perform an ANCOVA
using ZAN-BPD as covariate. Subsequent linear regres-
sions for HC and BN patients were performed to deter-
mine the nature of this interaction. In HCs, multivariate
regression including all 6 mentalizing measures showed
that the ZAN-BPD was not significantly associated with
mentalizing, F(6,48) = 1.19, p = .26. However, when the
RFQ-C and the RMET were tested separately, both were
found to be significantly associated with the ZAN-BPD
Table 2 One-way analysis of variance of demographic features,
symptom severity and measures of mentalizing
df SS MS F d p
Age
Between groups 1 70.22 70.22 .92 .17 .34
Within groups 138 10,553.47 76.47
Total 138 10,623.70
BMI
Between groups 1 62.61 62.61 2.26 .41 .14
Within groups 76 2109.09 27.75
Total 77 2171.70
EDE-Q <.001
Between groups 1 212.19 212.19 333.76 4.49
Within groups 76 48.32 .64
Total 77 260.51
DASS-21 21,105.44 209.57
Between groups 1 21,105.44 100.71 4.62 <.001
Within groups 76 10,171.28
Total 77 31,276.73
DR-S Self
Between groups 1 36.52 36.52 39.00 1.08 <.001
Within groups 101 129.23 .94
Total 102 165.75
DR-S Mother
Between groups 1 13.86 13.86 16.20 .67 <.001
Within groups 138 118.09 .86
Total 139 131.95
DR-S Father
Between groups 1 5.52 5.52 6.66 .45 <.001
Within groups 138 114.24 .83
Total 139 119.76
RMET
Between groups 1 123.92 123.92 9.78 .61 <.001
Within groups 101 1291.87 12.66
Total 102 1415.79
RFQ-C
Between groups 1 741.69 741.69 51.52 1.40 <.001
Within groups 101 1468.32 14.39
Total 102 2210.02
RFQ-U
Between groups 1 1272.71 1272.71 89.32 1.86 <.001
Within groups 101 1453.40 14.25
Total 102 2726.11
ZAN-BPD
Between groups 1 2354.05 2354.05 104.20 2.74 <.001
Within groups 76 1717 22.59
Total 77 4071.05
Note. For EDE-Q, DASS-21, and ZAN-BPD total scores are reported
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(F(8,16) = 5.13, p = < .01, and F(8,48) = 3.16, p = < .05).
Specifically, higher scores on the ZAN-BPD were associ-
ated with lower scores on the RMET and on the RFQ-C.
In BN patients, conversely the multivariate test was
found to be significant (F(1,120) = 1.36, p < .05), indicat-
ing that higher scores on the ZAN-BPD were associated
with worse mentalizing when all six measures of menta-
lizing were considered. Specifically, when looking at sin-
gle effects, RFQ-U (F(20,32) = 2.01, p = < .05) and RMET
(F(20,32) = 2.60, p = < .01) were significantly associated
with the ZAN-BPD, with higher scores on the
ZAN-BPD predicting lower scores on the RMET and
higher scores on the RFQ-U.
In order to further analyse the influence of comorbid
BPD symptoms on mentalizing, we compared BN pa-
tients with high and low ZAN-BPD scores (using a
cut-off of 9; [45]) on all measures of mentalizing using
t-tests. No significant differences between both groups
of patients were found, with one exception. BN patients
with low BPD symptoms scored significantly lower
(t(51) = 2.61, p < .05) on the RFQ-U scale, indicating less
impairments in mentalizing.
As for the second set of hypotheses, there were no sig-
nificant correlations between ED symptom severity
(EDE-Q Global score) and any of the measures of men-
talizing. However, the EDE-Q Global score was signifi-
cantly correlated with general psychological distress
(DASS-21), r = .41, p < .01. Moreover, the DASS-21 was
significantly correlated with the ZAN-BPD, r = .49, p
< .01, and with two measures of mentalizing: the RFQ-U,
r = .44, p < .01, and the RFQ-C, r = .30, p < .05. Also the
ZAN-BPD was significantly correlated with two of the
measures of mentalization: the RFQ-U, r = .37, p < .01,
and the DR-S Self, r = −.32, p < .05.
For testing the third study hypothesis, three
mediation models were tested using Group as the
independent variable, ZAN-BPD as the mediator, and
RFQ-C, RFQ-U and DR-S Self respectively as
dependent variables. As shown in Fig. 2 1, 2 and 3, both
the direct and indirect effects of Group were signifi-
cantly associated with poorer performances on
mentalizing measures in all models.
Discussion
The goal of the current study was to assess differences
in mentalizing abilities between BN patients and HCs.
The first hypothesis of the study was that BN subjects
would have significantly lower levels of mentalizing.
However, we expected that these differences in mentaliz-
ing would level down when adjusting for comorbid BPD
symptoms. The first hypothesis was partially confirmed.
BN patients showed significantly lower scores on all
mentalizing measures (Fig. 1). However, it was not pos-
sible to control for the influence of BPD symptoms on
group differences as the homogeneity of regression
slopes assumption was not met.
In some previous studies, BN patients were found
to exhibit deficits in social cognition and particularly
in recognizing other people’s emotions through facial
expressions as assessed by the RMET [17]. In line
with those findings, the sample analyzed in the
current study reported significantly lower scores on
the RMET compared to HCs. Moreover, in the
present investigation, deficits in symbolization and
mentalizing were also demonstrated also in the ORI.
When asked to describe themselves and their signifi-
cant others, BN patients showed less complex object
representations in relation to both the self and others.
Fig. 1 Means and standard deviations of the mentalizing measures in both BN and HCs (BN=Bulimia Nervosa patients, HC = Healthy controls).
Mentalizing measures include the three subscales of the Differentiation-Relatedness Scale regarding the Self (DR-S Self), the Mother (DR-S Mother)
and the Father (DR-S Father), the Reading The Mind in The Eyes Test (RMET), and the Reflective Function Questionnaires Certainty (RFQ-C) and
Uncertainty (RFQ-U) subscales
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Descriptions were characterized by a stronger focus
on physical appearance and body qualities rather than
personality and psychological features. This is consist-
ent with the observation that ED patients exhibit high
levels of self-objectification and therefore have a ten-
dency to evaluate oneself by physical versus
non-physical means. In this respect, it could be spec-
ulated that self-objectification may be a subcompo-
nent, or may arise as an epiphenomenon, of poor
mentalizing. Boundaries between the self and others
were found to be often compromised with a tendency
to express polarized descriptions (characterized by
idealization or denigration) without an attempt to
integrate positive and negative aspects. These results
are in accordance with a previous study that adminis-
tered the ORI to a sample of mixed AN and BN pa-
tients finding impaired reflective symbolization of the
self and others [56].
Lastly, BN patients scored significantly higher than
HCs on the RFQ-U and significantly lower on the
RFQ-C. Both of these differences suggest impaired men-
talizing (hypomentalizing and hypermentalizing) in BN
patients, indicating a lack of insight into the mental
states of oneself and others.
Fig. 2 1 Mediation model with Group as independent variable, ZAN-BPD as mediator, and RFQ-C as dependent variable. Note. *p < .05, **p < .01, ***p
< .001. 2 Mediation model with Group as independent variable, ZAN-BPD as mediator, and RFQ-U as dependent variable. Note. *p < .05, **p < .01, ***p
< .001. 3 Mediation model with Group as independent variable, ZAN-BPD as mediator, and Self DR-S as dependent variable. Note. *p < .05,
**p < .01, ***p < .001
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These results seem to be in contrast with a previous
study by Pedersen et al. [50] in which reflective func-
tioning was analysed using the Reflective Functioning
Scale (RF; [35]) in a sample of BN patients and HCs. In
this study BN patients were found to have a more polar-
ized pattern in their RF abilities with more scores both
in the low and high range compared to HCs, who mainly
reported scores in the medium range. These findings
lead the authors to postulate that BN may develop and
persist despite good mentalizing abilities. However, they
also suggested that high RF scores could have resulted
from raters mistakenly rating pseudomentalizing or
hypermentalizing as high RF. This indeed remains a pos-
sibility as the RF scale does not adequately differentiate
genuine RF from hypermentalizing. The RFQ used in
the present study might be a better instrument for unco-
vering hypermentalizing and discrepancy of results be-
tween the two studies could therefore be better
explained by the use of different instruments. The re-
sults presented in this report are, however, consistent
with similar studies in patients with AN. Bers et al. [11]
found significantly reduced agency, reflectivity and re-
latedness (but not differentiation) compared to HCs.
Moreover, Bers et al. [10] using, as we did, the DR-S
scale of the ORI in AN, found significantly reduced
scores in descriptions of self, mother and father. This
suggests that some aspects of mentalizing may be simi-
larly impaired in both AN and BN, at least when the lat-
ter is complicated by BPD symptoms.
The second aim of the present study was to assess the
degree to which mentalizing was associated with ED
symptom severity in the BN sample. In this regard, pre-
vious studies have found a negative relationship between
mentalizing and ED symptoms [56]. Yet, in this study,
severity of ED symptoms was unrelated to mentalizing,
suggesting that mentalizing abilities could be better con-
ceptualized as a stable characteristic, independent of
symptom severity.
Conversely, ED symptom severity was correlated with
general psychological distress (DASS-21) which was cor-
related also with ZAN-BPD, suggesting that BN patients
with more severe ED and BPD symptoms experience
higher levels of psychological distress.
Furthermore, according to the third hypothesis of the
study, BPD features were found to partially mediate the
relationship between BN and indices of mentalizing
(RFQ-U, RFQ-C, DR-S Self ). However the direct effect
of BN on mentalizing continued to be significant after
controlling for ZAN-BPD score, indicating that both ED
and BPD symptoms contribute independently in deter-
mining low mentalizing. The results support the hypoth-
esis that impaired mentalizing is a characteristic of BN
and not only a by-product of a comorbid symptomatol-
ogy. However, current findings are limited by a relatively
small sample of patients with a fairly homogenous high
level of BPD features. Furthermore, for only three of the
administered measures of mentalizing was it possible to
test mediation models, restricting interpretation of the
results to certain domains of mentalizing, namely re-
flective functioning and reflective symbolization of the
self. The relationship between BN, BPD and other do-
mains of mentalizing, such as social cognition and re-
flective symbolization of others, remained less clear. It is
also a limitation that, for 62 of the 87 healthy controls,
we relied on the participants denying any history of EDs,
rather than using a structured ED instrument, as was
done for the last 25 controls.
Alongside, future research should consider additional
variables that can explain patients’ heterogeneity such as
age of onset, illness duration, presence of diagnostic
crossover, previous history of AN, and other comorbidi-
ties, especially mood disorders that have been previously
associated with poor mentalizing [6, 33]. A possible as-
sociation with mood received some support from our
study, in which the DASS-21 scores showed a significant
correlation with both RFQ scales. However, in the
current study it was not possible to further investigate
whether mood could account for part of the observed
variability between groups in mentalizing. Indeed,
DASS-21 did not meet assumptions for ANCOVA, and
it was not possible to use this variable as covariate.
Therefore, a possible direction for a further investigation
would be to replicate the study design in a larger sam-
ples of BN and AN patients with and without BPD
implementing the design with additional measures.
Moreover, the cross-sectional design of the study does
not allow for inferences about causation but only associ-
ations. Whether low scores in mentalizing are a predis-
posing factor for BN or a by-product of the illness
cannot be determined. Similarly, no conclusion can be
drawn about the relationship between level of mentaliz-
ing and ED symptom severity over time. For example, it
would be informative to analyze how both of these vari-
ables vary throughout treatment of BN. To address these
issues, there is a need of larger scale studies with both
community samples and currently ill patients, as well as
studies employing longitudinal and prospective designs.
Conclusion
Overall, the results of this study confirmed that patients
with BN exhibit impaired mentalizing in regard to both
the self and others. Furthermore, BPD features were
found to play a role in explaining these impairments by
partially mediating the relationship between BN and
some indices of mentalizing. In conclusion, our findings
lend empirical support for the hypothesis that impair-
ments in mentalizing could be key in the etiology and
maintenance of BN symptoms. It could be postulated
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that ED symptoms are used by patients as a maladaptive
coping strategy to overcome emotional and interper-
sonal difficulties rising from the inability to understand
behaviors in terms of mental states. Results of this study
can thus be used to inform future directions of clinical
practice. In this respect, BN patients could benefit from
the development of treatment protocols aiming to im-
plement mentalizing abilities. A randomized trial of
Mentalization Based Therapy for Eating Disorders
(MBT-ED) has been published with some promising re-
sults [53] and MBT-ED has been described in detail [54].
In turn, improving mentalizing could lead to better
treatment outcomes and lower relapse rates. However,
additional research will be needed to further validate this
hypothesis.
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